Connection
Brian Stauffer to Nebivolol
This is a "connection" page, showing publications Brian Stauffer has written about Nebivolol.
|
|
Connection Strength |
|
 |
|
 |
|
0.929 |
|
|
|
-
Stauffer BL, Dow CA, Diehl KJ, Bammert TD, Greiner JJ, DeSouza CA. Nebivolol, But Not Metoprolol, Treatment Improves Endothelial Fibrinolytic Capacity in Adults With Elevated Blood Pressure. J Am Heart Assoc. 2017 Nov 09; 6(11).
Score: 0.595
-
Huck DM, Rosenberg MA, Stauffer BL. Nebivolol and incident cardiovascular events in hypertensive patients compared with nonvasodilatory beta blockers. J Hypertens. 2022 05 01; 40(5):1019-1029.
Score: 0.200
-
Diehl KJ, Stauffer BL, Dow CA, Bammert TD, Brunjes DL, Greiner JJ, DeSouza CA. Chronic Nebivolol Treatment Suppresses Endothelin-1-Mediated Vasoconstrictor Tone in Adults With Elevated Blood Pressure. Hypertension. 2016 06; 67(6):1196-204.
Score: 0.134